Author: Shaun Franks - Page 2

Liver-Healthy Diet: Science-Backed Nutrition Strategies for Fatty Liver and Hepatic Disease

Liver-Healthy Diet: Science-Backed Nutrition Strategies for Fatty Liver and Hepatic Disease
18 January 2026 Shaun Franks

A liver-healthy diet based on the Mediterranean pattern can reduce liver fat, lower enzymes, and reverse early fatty liver disease. Learn what to eat, what to avoid, and how real people are healing their livers with food.

Color Blindness: Understanding Red-Green Defects and How They're Passed Down

Color Blindness: Understanding Red-Green Defects and How They're Passed Down
17 January 2026 Shaun Franks

Red-green color blindness affects 8% of men and 0.5% of women worldwide due to X-linked genetic inheritance. Learn how it works, how it's passed down, and what tools can help.

Nonalcoholic Fatty Liver Disease: Risks and How to Prevent It

Nonalcoholic Fatty Liver Disease: Risks and How to Prevent It
16 January 2026 Shaun Franks

MASLD, formerly called NAFLD, affects 1 in 4 adults worldwide and is linked to obesity, diabetes, and poor metabolism. Learn how weight loss, diet, and exercise can reverse it before it leads to liver damage.

Metformin Extended-Release vs Immediate-Release: Which Is Better for Stomach Upset?

Metformin Extended-Release vs Immediate-Release: Which Is Better for Stomach Upset?
15 January 2026 Shaun Franks

Metformin extended-release reduces stomach side effects compared to immediate-release, helping more people stick with their diabetes treatment. Learn how the two forms differ, what studies show, and who should choose which.

Population Pharmacokinetics: How Data Proves Drug Equivalence

Population Pharmacokinetics: How Data Proves Drug Equivalence
14 January 2026 Shaun Franks

Population pharmacokinetics uses real-world patient data to prove drug equivalence across diverse populations, replacing outdated methods that rely on healthy volunteers. It's now essential for biosimilars, narrow therapeutic index drugs, and regulatory submissions.

Vancomycin and Vancomycin Infusion Reaction: What You Need to Know About Infusion-Related Reactions

Vancomycin and Vancomycin Infusion Reaction: What You Need to Know About Infusion-Related Reactions
13 January 2026 Shaun Franks

Vancomycin infusion reaction, once called red man syndrome, is a preventable reaction caused by fast IV administration. Learn the symptoms, how to stop it, and why the old term is outdated and harmful.

How to Coordinate Multiple Prescriptions to Avoid Conflicts

How to Coordinate Multiple Prescriptions to Avoid Conflicts
11 January 2026 Shaun Franks

Learn how to safely manage multiple prescriptions by using one pharmacy, syncing refills, using pill organizers, and getting annual medication reviews to avoid dangerous drug interactions and hospital visits.

Fluoroquinolone Antibiotics and NSAIDs: Higher Risk of Nerve and Kidney Damage When Used Together

Fluoroquinolone Antibiotics and NSAIDs: Higher Risk of Nerve and Kidney Damage When Used Together
10 January 2026 Shaun Franks

Taking fluoroquinolone antibiotics with NSAIDs like ibuprofen raises the risk of serious, sometimes permanent nerve and kidney damage. Learn who's most at risk and what safer alternatives exist.

Ethnicity and Drug Response: How Genetics Shape Medication Effectiveness

Ethnicity and Drug Response: How Genetics Shape Medication Effectiveness
8 January 2026 Shaun Franks

Ethnicity influences how drugs work due to genetic differences in metabolism. Learn how genes like CYP2C19 and HLA-B*15:02 affect drug safety and effectiveness across populations-and why genetics, not race, should guide treatment.

Nosebleeds Linked to Medications: Common Causes and How to Prevent Them

Nosebleeds Linked to Medications: Common Causes and How to Prevent Them
7 January 2026 Shaun Franks

Nosebleeds can be caused by common medications like aspirin, ibuprofen, and blood thinners. Learn the top causes, how to stop them, and what to do to prevent them without stopping your prescriptions.

APOL1 Genetic Risk: How African Ancestry Increases Kidney Disease Risk

APOL1 Genetic Risk: How African Ancestry Increases Kidney Disease Risk
5 January 2026 Shaun Franks

APOL1 genetic variants explain nearly 70% of the excess kidney disease risk in people of African ancestry. Learn how these inherited mutations work, who should be tested, and what steps can reduce your risk.

Therapeutic Equivalence Codes: How the FDA Determines Which Generics Can Be Substituted

Therapeutic Equivalence Codes: How the FDA Determines Which Generics Can Be Substituted
4 January 2026 Shaun Franks

Learn how the FDA uses therapeutic equivalence codes to determine which generic drugs can be safely substituted for brand-name medications. Understand A and B ratings, why some generics aren't interchangeable, and how this system saves billions in healthcare costs.